Poorly Differentiated Thyroid Gland Carcinoma

Poorly Differentiated Thyroid Gland Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04544111	PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer	active not recruiting	Phase 2	19	Memorial Sloan Kettering Cancer CenterOTHER	1	Sep 17, 2026	clinicaltrials
NCT02152995	Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer	active not recruiting	Phase 2	34	National Cancer Institute (NCI)NIH	1	Aug 28, 2026	clinicaltrials